P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates

This publication has 43 references indexed in Scilit:

• Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization
  Molecular Microbiology, 1997
• Direct evidence that asparagine at position 108 of the Plasmodium falciparum dihydrofolate reductase is involved in resistance to antifolate drugs in Tanzania
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1996
• Iron, but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malaria
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1995
• Mating Patterns in Malaria Parasite Populations of Papua New Guinea
  Science, 1995
• A mutation-specific PCR system to detect sequence variation in the dihydropteroate synthetase gene of Plasmodium falciparum
  Molecular and Biochemical Parasitology, 1995
• Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum
  Molecular and Biochemical Parasitology, 1995
• Sequence Variation of the Hydroxymethyldihydropterin Pyrophosphokinase: Dihydropteroate Synthase Gene in Lines of the Human Malaria Parasite, Plasmodium falciparum, with Differing Resistance to Sulfadoxine
  European Journal of Biochemistry, 1994
• Malaria-a neglected disease?
  Parasitology, 1992
• De novo and salvage biosynthesis of pteroylpentaglutamates in the human malaria parasite, Plasmodium falciparum
  Molecular and Biochemical Parasitology, 1989
• SUSCEPTIBILITY OF PLASMODIUM FALCIPARUM TO PYRIMETHAMINE AND SULFADOXINE/PYRIMETHAMINE IN KISUMU, KENYA
  The Lancet, 1982